Salix Pharmaceuticals, Ltd. Outlines Data Presentations at American Association for Study of Liver Diseases Annual Meeting
Published: Nov 01, 2013
Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that presentations related to the investigation of rifaximin are scheduled to take place during the 64th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD). AASLD is being held in Washington, DC November 1-5 2013.
Help employers find you! Check out all the jobs and post your resume.